S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
Log in

NASDAQ:CDLX - Cardlytics Stock Price, Forecast & News

$32.60
+0.12 (+0.37 %)
(As of 04/2/2020 09:35 AM ET)
Today's Range
$32.40
Now: $32.60
$32.80
50-Day Range
$29.49
MA: $64.67
$102.99
52-Week Range
$14.14
Now: $32.60
$107.50
Volume14,869 shs
Average Volume1.53 million shs
Market Capitalization$744.14 million
P/E RatioN/A
Dividend YieldN/A
Beta2.53
Cardlytics, Inc. operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. It also provides solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded in 2008 and is headquartered in Atlanta, Georgia.
Read More
Cardlytics logo

Industry, Sector and Symbol

Industry Computer programming, data processing, & other computer related
Sub-IndustryN/A
SectorBusiness Services
Current SymbolNASDAQ:CDLX
CUSIPN/A
Phone888-798-5802

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$210.43 million
Book Value$6.28 per share

Profitability

Net Income$-17,140,000.00

Miscellaneous

EmployeesN/A
Market Cap$744.14 million
Next Earnings Date5/14/2020 (Estimated)
OptionableNot Optionable

Receive CDLX News and Ratings via Email

Sign-up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter.


Cardlytics (NASDAQ:CDLX) Frequently Asked Questions

How has Cardlytics' stock been impacted by COVID-19 (Coronavirus)?

Cardlytics' stock was trading at $45.83 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CDLX stock has decreased by 29.2% and is now trading at $32.47. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Cardlytics?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There are currently 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Cardlytics.

When is Cardlytics' next earnings date?

Cardlytics is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for Cardlytics.

How were Cardlytics' earnings last quarter?

Cardlytics Inc (NASDAQ:CDLX) posted its earnings results on Tuesday, March, 3rd. The company reported $0.18 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.04 by $0.14. The company had revenue of $69.29 million for the quarter, compared to analyst estimates of $69.19 million. Cardlytics had a negative net margin of 8.15% and a negative return on equity of 19.49%. The firm's revenue for the quarter was up 44.9% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.06) earnings per share. View Cardlytics' earnings history.

What guidance has Cardlytics issued on next quarter's earnings?

Cardlytics issued an update on its first quarter 2020 After-Hours earnings guidance on Tuesday, March, 3rd. The company provided EPS guidance of for the period. The company issued revenue guidance of $43.5-46.5 million, compared to the consensus revenue estimate of $52.77 million.

What price target have analysts set for CDLX?

7 equities research analysts have issued twelve-month price objectives for Cardlytics' shares. Their forecasts range from $26.00 to $100.00. On average, they anticipate Cardlytics' share price to reach $62.17 in the next twelve months. This suggests a possible upside of 91.5% from the stock's current price. View analysts' price targets for Cardlytics.

Has Cardlytics been receiving favorable news coverage?

Headlines about CDLX stock have been trending very negative recently, InfoTrie reports. The research firm identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cardlytics earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutCardlytics.

Who are some of Cardlytics' key competitors?

What other stocks do shareholders of Cardlytics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include Trade Desk (TTD), Alibaba Group (BABA), Caterpillar (CAT), Micron Technology (MU), Advanced Micro Devices (AMD), NVIDIA (NVDA), Square (SQ), Crispr Therapeutics (CRSP), Roku (ROKU) and Netflix (NFLX).

Who are Cardlytics' key executives?

Cardlytics' management team includes the following people:
  • Mr. Scott D. Grimes, Co-Founder, CEO & Director (Age 56)
  • Ms. Lynne Marie Laube, Co-Founder, COO & Director (Age 49)
  • Mr. David Evans, CFO & Head of Corp. Devel.
  • Mr. Sathish Gaddipati, Chief Technology Officer (Age 52)
  • Mr. Kirk L. Somers, Chief Legal & People Officer (Age 54)

When did Cardlytics IPO?

(CDLX) raised $76 million in an initial public offering (IPO) on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

What is Cardlytics' stock symbol?

Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."

How do I buy shares of Cardlytics?

Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cardlytics' stock price today?

One share of CDLX stock can currently be purchased for approximately $32.47.

How big of a company is Cardlytics?

Cardlytics has a market capitalization of $741.29 million and generates $210.43 million in revenue each year. The company earns $-17,140,000.00 in net income (profit) each year or ($0.75) on an earnings per share basis.  View additional information about Cardlytics.

What is Cardlytics' official website?

The official website for Cardlytics is http://www.cardlytics.com/.

How can I contact Cardlytics?

Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The company can be reached via phone at 888-798-5802 or via email at [email protected]


MarketBeat Community Rating for Cardlytics (NASDAQ CDLX)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  179 (Vote Outperform)
Underperform Votes:  232 (Vote Underperform)
Total Votes:  411
MarketBeat's community ratings are surveys of what our community members think about Cardlytics and other stocks. Vote "Outperform" if you believe CDLX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CDLX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel